Dec 21, 2020: Day 7
Due to my age and moderate-to-severe symptoms, the physician recommended me as a candidate for a bamlanivimab (synthetic monoclonal antibody) infusion at a local hospital. I elected to do that.
The following day I received the MAb infusion as an out-patient in a new, high-tech, outpatient infusion center in the hospital. Being a biopharma…
